← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 1, 2010Last known activity
Aug 31, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 7 trials)
Phase 2 (1 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Recent trials (15)
- NCT07118059Lead sponsorPhase 2Aug 31, 2025
- NCT07118059Sponsor investigatorPhase 2Aug 31, 2025
- NCT07081152Lead sponsorN/AJul 24, 2025
- NCT07081152Sponsor investigatorN/AJul 24, 2025
- NCT06038656Sponsor investigatorN/ANov 30, 2023
- NCT06038656Lead sponsorN/ANov 30, 2023
- NCT06038656Reponsible party - principal investigatorN/ANov 30, 2023
- NCT06038656OfficialN/ANov 30, 2023
- NCT05220735CollaboratorN/AMar 7, 2022
- NCT05168085Reponsible party - principal investigatorN/AFeb 13, 2020
- NCT05168085Lead sponsorN/AFeb 13, 2020
- NCT02045784CollaboratorN/ASep 30, 2014
- NCT01092377Overall official - principal investigatorN/AFeb 1, 2010
- NCT01092377Study directorN/AFeb 1, 2010
- NCT01092377Lead sponsorN/AFeb 1, 2010
Details
- Last known activity
- Aug 31, 2025